octachloronaphthalene has been researched along with eicosapentaenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janosch, C; Szechinski, J; Zawadzki, M | 1 |
| Camfield, D; Kean, JD; Kras, M; Sarris, J; Scholey, A; Silberstein, R; Stough, C | 1 |
2 trial(s) available for octachloronaphthalene and eicosapentaenoic acid
| Article | Year |
|---|---|
Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control.
Topics: Aged; Animals; Complementary Therapies; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Lipids; Male; Middle Aged; Osteoarthritis; Pain; Perna; Quality of Life; Treatment Outcome | 2013 |
A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) exp
Topics: Adolescent; Adolescent Behavior; Affect; Animals; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Cognition; Cysteine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Female; Humans; Lipids; Male; New Zealand; Perna; Treatment Outcome | 2013 |